Prospective Surveillance Pilot of Rivaroxaban Safety within the US Food and Drug Administration Sentinel System

Basic Details
Date
Friday, August 25, 2017
Type
Presentation
Medical Product
rivaroxaban
Health Outcome(s)
gastrointestinal (GI) bleed
intracranial hemorrhage
ischemic stroke
Presenter(s)

Elizabeth Chrischilles